P

Assignee

ACTUATE THERAPEUTICS INC

US7 patents

Top patents by PatentIndex Score

US11136334B2Oct 5, 2021

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

ACTUATE THERAPEUTICS INC5 citations81
US11407759B2Aug 9, 2022

Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

ACTUATE THERAPEUTICS INC4 citations70
US11510904B2Nov 29, 2022

Methods of treating malignant lymphoproliferative disorders

ACTUATE THERAPEUTICS INC2 citations68
US12145943B2Nov 19, 2024

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

ACTUATE THERAPEUTICS INC0 citations59
US12116374B2Oct 15, 2024

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

ACTUATE THERAPEUTICS INC0 citations59
US11980607B2May 14, 2024

Methods of treating malignant lymphoproliferative disorders

ACTUATE THERAPEUTICS INC1 citations57
US12083098B2Sep 10, 2024

Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form β inhibitors

ACTUATE THERAPEUTICS INC0 citations51